Low-level amplification of oncogenes correlates inversely with age for patients with nontypical meningiomas.

[1]  Arie Perry,et al.  Identification of Gene Markers Associated With Aggressive Meningioma by Filtering Across Multiple Sets of Gene Expression Arrays , 2011, Journal of neuropathology and experimental neurology.

[2]  Sally Freels,et al.  Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. , 2010, Neuro-oncology.

[3]  T. Hyslop,et al.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma , 2010, Radiation oncology.

[4]  M. Ferrer,et al.  Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. , 2010, Histology and histopathology.

[5]  D. Louis,et al.  Genomic Profiling of Atypical Meningiomas Associates Gain of 1q With Poor Clinical Outcome , 2009, Journal of neuropathology and experimental neurology.

[6]  K. Mori,et al.  The Sterol-sensing Endoplasmic Reticulum (ER) Membrane Protein TRC8 Hampers ER to Golgi Transport of Sterol Regulatory Element-binding Protein-2 (SREBP-2)/SREBP Cleavage-activated Protein and Reduces SREBP-2 Cleavage* , 2009, The Journal of Biological Chemistry.

[7]  Michael R. Green,et al.  F-Box Protein FBXO31 Mediates Cyclin D1 Degradation to Induce G1 Arrest Following DNA Damage , 2009, Nature.

[8]  E. Eichler,et al.  Human copy number polymorphic genes , 2009, Cytogenetic and Genome Research.

[9]  C. Beetz,et al.  Methylation-specific multiplex ligation-dependent probe amplification in meningiomas , 2008, Journal of Neuro-Oncology.

[10]  Philippe Froguel,et al.  Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. , 2007, Human molecular genetics.

[11]  R. Mirimanoff,et al.  Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. , 2007, International journal of radiation oncology, biology, physics.

[12]  Alberto Orfao,et al.  Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. , 2007, Neuro-oncology.

[13]  J. Rey,et al.  Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma. , 2007, Cancer genetics and cytogenetics.

[14]  A. Órfão,et al.  New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology. , 2003, Journal of Clinical Oncology.

[15]  S. Artan,et al.  Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. , 2002, Acta neurologica Belgica.

[16]  M. Schmid,et al.  Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF , 2000, Oncogene.

[17]  K. Hoang-Xuan,et al.  Frequent Loss of 1p32 Region but no Mutation if the p18 Tumor Suppressor Gene in Meningiomas , 2000, Journal of Neuro-Oncology.

[18]  J. Rey,et al.  High-resolution analysis of chromosome arm 1p alterations in meningioma. , 2000, Cancer genetics and cytogenetics.

[19]  J. Bischoff,et al.  The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. , 1999, Trends in cell biology.

[20]  B. Scheithauer,et al.  Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. , 1998, Mayo Clinic proceedings.

[21]  M. Wolter,et al.  Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Black,et al.  Expression and activation of epidermal growth factor receptors in meningiomas. , 1997, Journal of neurosurgery.

[23]  K. Tamai,et al.  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.

[24]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[25]  M. Berger,et al.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.

[26]  D. Louis WHO classification of tumours of the central nervous system , 2007 .

[27]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .